Intraoperative 5-fluorouracil Augmentation of Trabeculectomy
Status:
COMPLETED
Trial end date:
2003-06-01
Target enrollment:
Participant gender:
Summary
5-fluorouracil (5FU) is an antimetabolite that has been demonstrated to have beneficial effects when injected into the subconjunctival space after glaucoma surgery (trabeculectomy). The hypothesis of this study is that a similar beneficial effect can be achieved with a single intraoperative application of 5FU. This hypothesis is tested with a randomized control study.